STCOSD
SPPI

Sageworth Trust Company of South Dakota’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Sageworth Trust Company of South Dakota’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-94
Closed – – 697
2022
Q2 		$0 Hold
94
– – ﹤0.01% 711
2022
Q1 		$0 Sell
94
-424
-82% -$390 ﹤0.01% 713
2021
Q4 		$1K Buy
+518
New +$926 ﹤0.01% 708

Other funds holding SPPI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sageworth Trust Company of South Dakota's SPPI Position: Q3 2022 in Review

Sageworth Trust Company of South Dakota sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2022, closing a stake of 94 shares.

Sageworth Trust Company of South Dakota first reported a position in SPPI in Q4 2021 and held it in 3 quarters. The position peaked at $1K in Q4 2021. 75 funds tracked by Wall St. Rank hold SPPI as of Q3 2022.

  • Sageworth Trust Company of South Dakota reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2022 after selling out during the quarter.
  • Sageworth Trust Company of South Dakota sold 94 Spectrum Pharmaceuticals Inc shares in Q3 2022.
  • Sageworth Trust Company of South Dakota first reported a position in Spectrum Pharmaceuticals Inc in Q4 2021 and held it in 3 quarters.
  • Sageworth Trust Company of South Dakota's Spectrum Pharmaceuticals Inc position peaked at $1K in Q4 2021.
  • 75 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2022.

Based on Sageworth Trust Company of South Dakota's 13F filing for Q3 2022, filed 2 Nov 2022.